Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Treatments for Bruxism-Induced Myalgia
NCT06583551Completed
- Sponsor
- Sağlık Bilimleri Üniversitesi
- Start
- Jan 2021
- Primary completion
- Mar 2021
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of botulinum toxin type A, methocarbamol and acetaminophen in myalgia and bruxism (4 arms), sponsored by Sağlık Bilimleri Üniversitesi. Primary endpoints: Visual Analogue Scale for Pain at 12 weeks, Maximum Painless Mouth Opening at 12 weeks and 1 more. Started Jan 2021; status: completed.
02
Drugs
botulinum toxin type Amethocarbamolacetaminophen
03
Conditions
myalgiabruxism
Beyond the preview
Go deeper on NCT06583551.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06583551.